Radiopharmaceuticals for cardiovascular nuclear medicine

A survey is given of cardiovascular radiopharmaceuticals subdivided into the following six major groups: 1) tracers for cardiac blood pool studies; 2) agents for perfusion scintigraphy; 3) metabolic substrates and their analogs; 4) infarct avid agents; 5) specific cardiac receptor ligands; and 6) labeled cardiac antibodies, leukocytes and norepinephrine storage analogs. (Auth.)